Eculizumab cessation in atypical hemolytic uremic syndrome

Publisher's Note: There is an Inside Blood Commentary on this article in this issue.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2017-07, Vol.130 (3), p.368-372
Hauptverfasser:	Merrill, Samuel A., Brittingham, Zachary D., Yuan, Xuan, Moliterno, Alison R., Sperati, C.John, Brodsky, Robert A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - economics Antibodies, Monoclonal, Humanized - therapeutic use Atypical Hemolytic Uremic Syndrome - drug therapy Atypical Hemolytic Uremic Syndrome - economics Atypical Hemolytic Uremic Syndrome - therapy Drug Administration Schedule Drug Costs Female Follow-Up Studies Humans Letter to Male Middle Aged Recurrence Renal Dialysis - statistics & numerical data Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Publisher's Note: There is an Inside Blood Commentary on this article in this issue.
ISSN:	0006-4971 1528-0020
DOI:	10.1182/blood-2017-02-770214